journal article·2026-02

Copper-doxorubicin nanodot-based dual catalytic metal prodrug liposome for enhanced chemotherapy and Chemodynamic Combination Therapychemodynamic combination therapy

Chuanyong Fan, Yao Zhou, Yihua Mei, Kaifang Wu, Meng Wang, Limeng Chen, Hongyan Liu, Zehao Dong, Lu Xu

Nano Today· Volume 67
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (44)

Show source-provided references
1. Metallodrugs in cancer nanomedicine10.1039/D1CS00468A ↗
2. Nanoenabled Intracellular Metal Ion Homeostasis Regulation for Tumor Therapy10.1002/advs.202306203 ↗
3. Multifunctional calcium–manganese nanomodulator provides antitumor treatment and improved immunotherapy via reprogramming of the tumor microenvironment10.1021/acsnano.3c01215 ↗
4. The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment10.1038/s41591-023-02369-6 ↗
5. Microfluidized dextran microgels loaded with Cisplatin/SPION lipid nanotherapeutics for local colon cancer treatment via oral administration10.1002/adhm.202201140 ↗
6. Targeted nanomedicine in cisplatin-based cancer therapeutics10.1016/j.jconrel.2022.03.049 ↗
7. TRPA1 modulation by Sigma-1 receptor prevents oxaliplatin-induced painful peripheral neuropathy10.1093/brain/awac273 ↗
8. Platinum-based drugs for cancer therapy and anti-tumor strategies10.7150/thno.69424 ↗
9. A dihydroartemisinin-loaded nanoreactor motivates anti-cancer immunotherapy by synergy-induced ferroptosis to activate Cgas/STING for reprogramming of macrophage10.1002/adhm.202301561 ↗
10. Engineering oxaliplatin prodrug nanoparticles for second near-infrared fluorescence imaging-guided immunotherapy of colorectal cancer10.1002/smll.202007882 ↗
11. Nanomedicine in cancer therapy10.1038/s41392-023-01536-y ↗
12. Nanomedicine tumor targeting10.1002/adma.202312169 ↗
13. Cancer nanomedicine10.1038/s41568-022-00496-9 ↗
14. pH-responsive hybrid platelet membrane-coated nanobomb with deep tumor penetration ability and enhanced cancer thermal/chemodynamic therapy10.7150/thno.68996 ↗
15. Self-assembled FeS-based cascade bioreactor with enhanced tumor penetration and synergistic treatments to trigger robust cancer immunotherapy10.1016/j.apsb.2021.05.005 ↗
16. Metal-polyphenol self-assembled nanodots for NIR-II fluorescence imaging-guided chemodynamic/photodynamic therapy-amplified ferroptosis10.1016/j.actbio.2024.07.017 ↗
17. Metal-polyphenol nanodots loaded hollow MnO2 nanoparticles with a “dynamic protection” property for enhanced cancer chemodynamic therapy10.1016/j.jcis.2022.12.088 ↗
18. Synthesis of copper peroxide nanodots for H2O2 Self-supplying chemodynamic therapy10.1021/jacs.9b03457 ↗
19. Antiferromagnetic pyrite as the tumor microenvironment-mediated nanoplatform for self-enhanced tumor imaging and therapy10.1002/adma.201701683 ↗
20. Copper(I) phosphide nanocrystals for in situ self-generation magnetic resonance imaging-guided photothermal-enhanced chemodynamic synergetic therapy resisting deep-seated tumor10.1002/adfm.201904678 ↗
21. Engineering 2D Cu-composed metal–organic framework nanosheets for augmented nanocatalytic tumor therapy10.1186/s12951-022-01250-x ↗
22. Novel flexible Fenton-like catalyst: unique CuO nanowires arrays on copper mesh with high efficiency across a wide pH range10.1016/j.scitotenv.2018.08.022 ↗
23. Engineering dual catalytic nanomedicine for autophagy-augmented and ferroptosis-involved cancer nanotherapy10.1016/j.biomaterials.2022.121668 ↗
24. Copper nanodots-based hybrid hydrogels with multiple enzyme activities for acute and infected wound repair
25. Iron-doxorubicin prodrug loaded liposome nanogenerator programs multimodal ferroptosis for efficient cancer therapy
26. Remote loading paclitaxel–doxorubicin prodrug into liposomes for cancer combination therapy10.1016/j.apsb.2020.04.011 ↗
27. Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft10.1016/j.jconrel.2013.10.025 ↗
28. A solid lipid coated calcium peroxide nanocarrier enables combined cancer chemo/chemodynamic therapy with O2/H2O2 self-sufficiency10.1016/j.actbio.2020.12.036 ↗
29. A tumor microenvironment-responsive poly(amidoamine) dendrimer nanoplatform for hypoxia-responsive chemo/chemodynamic therapy10.1186/s12951-022-01247-6 ↗
30. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy10.1016/j.actbio.2023.04.003 ↗
31. Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative breast cancer10.1016/j.biomaterials.2023.122447 ↗
32. W. Zhang, P. Zhang, X. Xu, M. Li, S. Wang, H. Mu, K. Sun, Synergy effects of copper ion in doxorubicin-based chelate prodrug for cancer chemo-chemodynamic combination therapy, Drug Deliv 30 (n.d.) 2219426.10.1080/10717544.2023.2219426 ↗
33. Tumor microenvironment-activatable Fe-doxorubicin preloaded amorphous CaCO3 nanoformulation triggers ferroptosis in target tumor cells10.1126/sciadv.aax1346 ↗
34. Glutathione/pH-responsive copper-based nanoplatform for amplified chemodynamic therapy through synergistic cycling regeneration of reactive oxygen species and dual glutathione depletion10.1016/j.jcis.2023.08.043 ↗
35. Self-assembled copper-based nanoparticles for glutathione activated and enzymatic cascade-enhanced ferroptosis and immunotherapy in cancer treatment10.1002/smll.202301148 ↗
36. Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs10.1016/j.actbio.2021.07.023 ↗
37. Protein nanoparticles containing Cu(II) and DOX for efficient chemodynamic therapy via self-generation of H2O210.1016/j.cclet.2020.06.031 ↗
38. Enhanced photodynamic therapy by reduced levels of intracellular glutathione obtained by employing a Nano-MOF with cuii as the active center10.1002/anie.201710800 ↗
39. Simultaneous fenton-like ion delivery and glutathione depletion by MnO2-based nanoagent to enhance chemodynamic therapy10.1002/anie.201712027 ↗
40. Trisulfide bond–mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity10.1126/sciadv.abc1725 ↗
41. Tumor microenvironment responsive hollow nanoplatform for triple amplification of oxidative stress to enhance cuproptosis-based synergistic cancer therapy10.1002/adhm.202202949 ↗
42. Dual-targeting nanozyme combined with aPD-L1-based immunotherapy for combating cancer recurrence and metastasis10.1016/j.mattod.2024.01.011 ↗
43. Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer10.1016/j.drup.2023.101005 ↗
44. Doxil® — The first FDA-approved nano-drug: Lessons learned10.1016/j.jconrel.2012.03.020 ↗